Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Golan

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|March 8, 2022
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficientJustin M Leach, Gary Cutter, Daniel Golan, et al.
Advances in Therapy|June 11, 2024
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel FumarateMark Gudesblatt, Barbara Bumstead, Marijean Buhse, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and cliniciansDaija A Jackson, Rachel Nicholson, Catherine Bergmann, et al.
Multiple Sclerosis and Related Disorders|March 25, 2023
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?Hans Bogaardt, Daniel Golan, Marissa A Barrera, et al.
Journal of Neurology|December 13, 2023
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosisThomas J Covey, Daniel Golan, Robert Sergott, et al.
Multiple Sclerosis and Related Disorders|May 19, 2026
Word finding difficulties in multiple sclerosis and its relation to cognitive impairment, fatigue and depressionMildred Tan, Hans Bogaardt, Marissa A Barrera, et al.
Multiple Sclerosis and Related Disorders|September 10, 2023
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosisCatherine Bergmann, Shenira Becker, Adreanna Watts, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2026
Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysisCatherine Bergmann, Daija Jackson, Rachel Nicholson, et al.
Multiple Sclerosis and Related Disorders|June 8, 2024
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functionsRinu Abraham, Amiya Waldman-Levi, Marissa A Barrera, et al.
Multiple Sclerosis and Related Disorders|February 19, 2026
Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment toolDaija A Jackson, Catherine S Bergmann, Jeffrey Wilken, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|March 8, 2022
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficientJustin M Leach, Gary Cutter, Daniel Golan, et al.
Advances in Therapy|June 11, 2024
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel FumarateMark Gudesblatt, Barbara Bumstead, Marijean Buhse, et al.
Multiple Sclerosis and Related Disorders|November 18, 2022
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and cliniciansDaija A Jackson, Rachel Nicholson, Catherine Bergmann, et al.
Multiple Sclerosis and Related Disorders|March 25, 2023
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?Hans Bogaardt, Daniel Golan, Marissa A Barrera, et al.
Journal of Neurology|December 13, 2023
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosisThomas J Covey, Daniel Golan, Robert Sergott, et al.
Multiple Sclerosis and Related Disorders|May 19, 2026
Word finding difficulties in multiple sclerosis and its relation to cognitive impairment, fatigue and depressionMildred Tan, Hans Bogaardt, Marissa A Barrera, et al.
Multiple Sclerosis and Related Disorders|September 10, 2023
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosisCatherine Bergmann, Shenira Becker, Adreanna Watts, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2026
Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysisCatherine Bergmann, Daija Jackson, Rachel Nicholson, et al.
Multiple Sclerosis and Related Disorders|June 8, 2024
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functionsRinu Abraham, Amiya Waldman-Levi, Marissa A Barrera, et al.
Multiple Sclerosis and Related Disorders|February 19, 2026
Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment toolDaija A Jackson, Catherine S Bergmann, Jeffrey Wilken, et al.
Pageof 5